The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities

Chronic liver diseases from varying etiologies generally lead to liver fibrosis and cirrhosis. Among them, non-alcoholic fatty liver disease (NAFLD) affects roughly one-quarter of the world population, thus representing a major and increasing public health burden. Chronic hepatocyte injury, inflamma...

Full description

Bibliographic Details
Main Authors: Marlene Sophia Kohlhepp, Hanyang Liu, Frank Tacke, Adrien Guillot
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2023.1129831/full
_version_ 1811167234298478592
author Marlene Sophia Kohlhepp
Hanyang Liu
Frank Tacke
Adrien Guillot
author_facet Marlene Sophia Kohlhepp
Hanyang Liu
Frank Tacke
Adrien Guillot
author_sort Marlene Sophia Kohlhepp
collection DOAJ
description Chronic liver diseases from varying etiologies generally lead to liver fibrosis and cirrhosis. Among them, non-alcoholic fatty liver disease (NAFLD) affects roughly one-quarter of the world population, thus representing a major and increasing public health burden. Chronic hepatocyte injury, inflammation (non-alcoholic steatohepatitis, NASH) and liver fibrosis are recognized soils for primary liver cancer, particularly hepatocellular carcinoma (HCC), being the third most common cause for cancer-related deaths worldwide. Despite recent advances in liver disease understanding, therapeutic options on pre-malignant and malignant stages remain limited. Thus, there is an urgent need to identify targetable liver disease-driving mechanisms for the development of novel therapeutics. Monocytes and macrophages comprise a central, yet versatile component of the inflammatory response, fueling chronic liver disease initiation and progression. Recent proteomic and transcriptomic studies performed at singular cell levels revealed a previously overlooked diversity of macrophage subpopulations and functions. Indeed, liver macrophages that encompass liver resident macrophages (also named Kupffer cells) and monocyte-derived macrophages, can acquire a variety of phenotypes depending on microenvironmental cues, and thus exert manifold and sometimes contradictory functions. Those functions range from modulating and exacerbating tissue inflammation to promoting and exaggerating tissue repair mechanisms (i.e., parenchymal regeneration, cancer cell proliferation, angiogenesis, fibrosis). Due to these central functions, liver macrophages represent an attractive target for the treatment of liver diseases. In this review, we discuss the multifaceted and contrary roles of macrophages in chronic liver diseases, with a particular focus on NAFLD/NASH and HCC. Moreover, we discuss potential therapeutic approaches targeting liver macrophages.
first_indexed 2024-04-10T16:05:48Z
format Article
id doaj.art-553d50b3d904423b83c38259ab514faf
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-04-10T16:05:48Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-553d50b3d904423b83c38259ab514faf2023-02-10T05:18:53ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2023-02-011010.3389/fmolb.2023.11298311129831The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunitiesMarlene Sophia KohlheppHanyang LiuFrank TackeAdrien GuillotChronic liver diseases from varying etiologies generally lead to liver fibrosis and cirrhosis. Among them, non-alcoholic fatty liver disease (NAFLD) affects roughly one-quarter of the world population, thus representing a major and increasing public health burden. Chronic hepatocyte injury, inflammation (non-alcoholic steatohepatitis, NASH) and liver fibrosis are recognized soils for primary liver cancer, particularly hepatocellular carcinoma (HCC), being the third most common cause for cancer-related deaths worldwide. Despite recent advances in liver disease understanding, therapeutic options on pre-malignant and malignant stages remain limited. Thus, there is an urgent need to identify targetable liver disease-driving mechanisms for the development of novel therapeutics. Monocytes and macrophages comprise a central, yet versatile component of the inflammatory response, fueling chronic liver disease initiation and progression. Recent proteomic and transcriptomic studies performed at singular cell levels revealed a previously overlooked diversity of macrophage subpopulations and functions. Indeed, liver macrophages that encompass liver resident macrophages (also named Kupffer cells) and monocyte-derived macrophages, can acquire a variety of phenotypes depending on microenvironmental cues, and thus exert manifold and sometimes contradictory functions. Those functions range from modulating and exacerbating tissue inflammation to promoting and exaggerating tissue repair mechanisms (i.e., parenchymal regeneration, cancer cell proliferation, angiogenesis, fibrosis). Due to these central functions, liver macrophages represent an attractive target for the treatment of liver diseases. In this review, we discuss the multifaceted and contrary roles of macrophages in chronic liver diseases, with a particular focus on NAFLD/NASH and HCC. Moreover, we discuss potential therapeutic approaches targeting liver macrophages.https://www.frontiersin.org/articles/10.3389/fmolb.2023.1129831/fullliver macrophageshepatocellular carcinomaimmunotherapynon-alcoholic steatohepatitismonocytestumor-associated macrophages
spellingShingle Marlene Sophia Kohlhepp
Hanyang Liu
Frank Tacke
Adrien Guillot
The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities
Frontiers in Molecular Biosciences
liver macrophages
hepatocellular carcinoma
immunotherapy
non-alcoholic steatohepatitis
monocytes
tumor-associated macrophages
title The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities
title_full The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities
title_fullStr The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities
title_full_unstemmed The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities
title_short The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities
title_sort contradictory roles of macrophages in non alcoholic fatty liver disease and primary liver cancer challenges and opportunities
topic liver macrophages
hepatocellular carcinoma
immunotherapy
non-alcoholic steatohepatitis
monocytes
tumor-associated macrophages
url https://www.frontiersin.org/articles/10.3389/fmolb.2023.1129831/full
work_keys_str_mv AT marlenesophiakohlhepp thecontradictoryrolesofmacrophagesinnonalcoholicfattyliverdiseaseandprimarylivercancerchallengesandopportunities
AT hanyangliu thecontradictoryrolesofmacrophagesinnonalcoholicfattyliverdiseaseandprimarylivercancerchallengesandopportunities
AT franktacke thecontradictoryrolesofmacrophagesinnonalcoholicfattyliverdiseaseandprimarylivercancerchallengesandopportunities
AT adrienguillot thecontradictoryrolesofmacrophagesinnonalcoholicfattyliverdiseaseandprimarylivercancerchallengesandopportunities
AT marlenesophiakohlhepp contradictoryrolesofmacrophagesinnonalcoholicfattyliverdiseaseandprimarylivercancerchallengesandopportunities
AT hanyangliu contradictoryrolesofmacrophagesinnonalcoholicfattyliverdiseaseandprimarylivercancerchallengesandopportunities
AT franktacke contradictoryrolesofmacrophagesinnonalcoholicfattyliverdiseaseandprimarylivercancerchallengesandopportunities
AT adrienguillot contradictoryrolesofmacrophagesinnonalcoholicfattyliverdiseaseandprimarylivercancerchallengesandopportunities